Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
MarketResearch.biz delivers in-depth insights on the global deep brain stimulation market in its upcoming report titled, “Global deep brain stimulation Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global deep brain stimulation market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global deep brain stimulation market report has been segmented on the basis of type, application, and region.
Deep brain stimulation (DBS) is a neurological procedure in which a brain pacemaker device in implanted in the brain that delivers electrical stimulation to specific target of brain. Leads are placed according to the symptoms noticed in the patient. Deep brain stimulation is used in movement disorder and is also effective in epilepsy, obsession compulsive disorder, etc.
Increasing government expenditure on healthcare sector, coupled with favorable reimbursement policies and technological advancements in development of brain stimulator with various benefits such as safer, better option compared to ablative surgical procedure, adjustment according to patient requirement, option available for future surgical approaches are major factors driving growth of the global deep brain stimulation market. In addition, increasing prevalence of chronic disease such as Parkinson's, dystonia, tremor, etc. and adoption of DBS from patient for treatment of chronic pain, failed pharmaceutical and more conservative therapies are other factors expected to support growth of the global deep brain stimulation market.
However, side effects associated with deep brain stimulation device such as infection on place of surgery, interference with magnet and other electronic devices, etc. are factors expected to hamper growth of the global deep brain stimulation market.
Technological advancements such as development of subthalamic nucleus stimulation, a new application of deep brain stimulation is expected to create new opportunities in terms of revenue to players operating in the market over the forecast period.
North America market is expected to dominate in the global deep brain stimulation market with higher market share as compared to other regional markets, and is expected to continue its dominance during the forecast period. This can be attributed to increasing incidences of Parkinson's diseases among population in this region and presence of prominent market players operating in countries in this region. Europe market accounts for second-largest revenue share in the global deep brain stimulation market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing government expenditure on healthcare sector in emerging economies in this region.
Global Deep Brain Stimulation Market Segmentation:
- Subthalamic DBS
- Globus Pallidus DBS
- Thalamic DBS
- Pedunculopontine nucleus DBS
- Chronic Pain
- Essential Tremor
- Obsessive compulsive disorder
- Parkinsons Disease
- Others (Alzheimer, tinnitus)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Medtronic, Inc.
- Boston Scientific Corporation
- ReShape Lifesciences Inc.
- Cyberonics, Inc.
- Jude Medical, Inc.
- NeuroPace, Inc.
- Zynex Medical, Inc.
- Neuronetics, Inc.
- Functional Neuromodulation, Ltd.
- MicroTransponder, Inc.
- NeuroSigma, Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!